# Dose-finding Study of Four Dosage Levels of an H7N9 Influenza Vaccine in Adults Between Ages of 18 Years and 65 Years

> **NCT01928472** · PHASE1 · COMPLETED · sponsor: **Novartis Vaccines** · enrollment: 402 (actual)

## Conditions studied

- H7N9 Influenza

## Interventions

- **BIOLOGICAL:** H7N9c low dose with adjuvant
- **BIOLOGICAL:** H7N9c medium dose with adjuvant
- **BIOLOGICAL:** H7N9c high dose with adjuvant
- **BIOLOGICAL:** H7N9c high dose without adjuvant

## Key facts

- **NCT ID:** NCT01928472
- **Lead sponsor:** Novartis Vaccines
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-08
- **Primary completion:** 2014-09
- **Final completion:** 2014-09
- **Target enrollment:** 402 (ACTUAL)
- **Last updated:** 2019-06-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01928472

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01928472, "Dose-finding Study of Four Dosage Levels of an H7N9 Influenza Vaccine in Adults Between Ages of 18 Years and 65 Years". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01928472. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*